About External Genital and Perianal Warts

Almost ANYONE Who Has Sex Can Get EGW

External genital and perianal warts (EGW) are caused by a virus called human papillomavirus (HPV). HPV is the most common infection passed from one person to another during sex.

Photo for illustrative purposes only. Not actual patients.

people icon

80%
of people who have sex get HPV at some point in their lives in the US

male female icon

Up to 360,000 women and men have EGW every year in the US

map icon

About 1 in 100 adults who have sex has EGW at any given time in the US

Think You Have EGW?

Here's what to look for

Small, skin-colored spots, either raised or flat, that may have a cauliflower-like shape

  • You may have itching or discomfort in your genital and/or anal area
  • Vaginal bleeding can happen when you have sexual intercourse
 
 

Where do they appear?

In women: on the vulva, vagina, cervix, groin, and around the anus

In men: on the penis, scrotum, groin, and around the anus

If you have oral sex: in the mouth or throat

Is Treatment Really Necessary?

Well, sometimes no. EGW can stay the same size or clear up on their own, but they can also increase in number and size. Why take a chance when you may be able to get rid of them sooner?

Most people need treatment to get rid of EGW, even though treatment does not get rid of the HPV infection.

How Are EGW Treated?

Your first instinct may be to skip the doctor and pick up some over-the-counter wart removers. Don't do it! They're just not made for your genital area and can cause even more pain and irritation. Leave it up to your doctor to tell you which treatment is right for you.

Prescription Medicines:

Prescribed by a doctor for use at home

Treatment

What it does

How to apply

How it's dosed

Imiquimod (cream)

Boosts immune system to fight off EGW

Once per night for 3.75% strength (3x/week for 5% strength) but both strengths must be washed off within 6-10 hours

3.75% dosing strength: once daily for up to 8 weeks

5% dosing strength: 3x/week for up to 16 weeks

Podofilox (solution or gel)

Destroys EGW tissue

2x/day

3 days on and 4 days off for up to 4 cycles

Sinecatechins
(VEREGEN®)
(ointment)

Clears away EGW

3x/day

Daily for up to 16 weeks

There are also things your dermatologist can do during your office visit. Your doctor will help decide what's right for you.

Are you pregnant? Call your doctor right away if you're pregnant and you or your partner has EGW. Your doctor will decide whether or not to treat your EGW.

EGW=external genital and perianal warts

Important Safety Information

Do not use VEREGEN® (sinecatechins) Ointment, 15% if you are allergic to any ingredient in this product. Do not use VEREGEN® Ointment, 15% for warts in the vagina, cervix, or inside the anus. Avoid contact with your eyes, nostrils and mouth while ointment is on your finger(s).

Avoid use of VEREGEN® on open wounds. Do not expose skin that has been treated with VEREGEN® to the sunlight, sunlamps or tanning beds. Tell your doctor if you are using any other type of skin product on the area to be treated. Avoid sexual contact (genital, anal or oral) when VEREGEN® Ointment, 15% is on your genital or perianal skin. If you do choose to have sexual contact, you must wash off the ointment carefully before having protected sexual contact as the ointment may weaken condoms and vaginal diaphragms.

Be sure to tell the doctor if you have a weak immune system, if you are pregnant or nursing a baby, or if you have used VEREGEN® before. Avoid using this product in patients younger than 18 years of age or for longer than 16 weeks. If your warts do not go away or come back after treatment contact your doctor.

The most common side effects with VEREGEN® Ointment, 15% are local skin and application site reactions including (incidence ≥20%): redness, itching, burning, pain, sores, swelling, hard spots, and rash with blisters.

For more information, consult your healthcare professional.

Please see Full Prescribing Information for VEREGEN®.

You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

VEREGEN® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.

Important Safety Information

Do not use VEREGEN® (sinecatechins) Ointment, 15% if you are allergic to any ingredient in this product. Do not use VEREGEN® Ointment, 15% for warts in the vagina, cervix, or inside the anus. Avoid contact with your eyes, nostrils and mouth while ointment is on your finger(s).

Avoid use of VEREGEN® on open wounds. Do not expose skin that has been treated with VEREGEN® to the sunlight, sunlamps or tanning beds. Tell your doctor if you are using any other type of skin product on the area to be treated. Avoid sexual contact (genital, anal or oral) when VEREGEN® Ointment, 15% is on your genital or perianal skin. If you do choose to have sexual contact, you must wash off the ointment carefully before having protected sexual contact as the ointment may weaken condoms and vaginal diaphragms.

Be sure to tell the doctor if you have a weak immune system, if you are pregnant or nursing a baby, or if you have used VEREGEN® before. Avoid using this product in patients younger than 18 years of age or for longer than 16 weeks. If your warts do not go away or come back after treatment contact your doctor.

The most common side effects with VEREGEN® Ointment, 15% are local skin and application site reactions including (incidence ≥20%): redness, itching, burning, pain, sores, swelling, hard spots, and rash with blisters.

For more information, consult your healthcare professional.

Please see Full Prescribing Information for VEREGEN®.

You are encouraged to report negative side effects of prescription drugs to the Food and Drug Administration (FDA). Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

VEREGEN® is indicated for the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.

Are you a Healthcare Professional?

This section includes technical information. If you're a US healthcare provider, click "Continue." Otherwise, click "Return" to keep reading the patient site.